Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

KARDIOGENICS, INC.

Filed by TENAGRITY SOLUTIONS, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
ecc34318-0c7d-40d4-a5e3-c4c0877f0ebd
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution

Literal federal measure citations: H.R.4016, S2296

DEF · Defense

Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution

Literal federal measure citations: H.R.4016, S2296

MED · Medical/Disease Research/Clinical Labs

Discussions with congressional offices and HHS re: client and how their product and work could save lives

HCR · Health Issues

Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.